Simon Lovestone - Profile and Journalist Details
Find journalists that align with your industry, location and vision. Unlock Simon Lovestone's full journalist profile, including location, coverage topics, current employer, biography and preferences. Sign up today and start building journalist relationships that fuel your startup's growth.
Get connected with journalists today
Simon Lovestone
Verified
Editorial Board Member, International Journal of Geriatric Psychiatry
Oxford
Beats
Health environment technology and science policy
Adult items.
Content
By Angela Hodges, Andrew Simmons Verified, Simon Lovestone, Michael Weiner| Neurology Verified AbstractObjective To determine whether transcriptional risk scores (TRSs), a summation of polarized expression levels of functional genes, reflect the risk of Alzheimer disease (AD). Methods Blood transcriptome data were from Caucasian participants, which included AD, mild cognitive impairment, and cognitively normal controls (CN) in the Alzheimer's Disease Neuroimaging Initiative (ADNI, n = 661) and AddNeuroMed (n = 674) cohorts.
Publisher Correction: Pattern of Altered Plasma Elemental Phosphorus, Calcium, Zinc, and Iron in Alzheimer’s Disease
By Magda Tsolaki, Bruno Vellas, Simon Lovestone, Hilkka Soinine| Nature Verified Correction to: Scientific Reports https://doi.org/10.1038/s41598-018-37431-8, published online 28 February 2019The original version of this Article contained an error in the title of the paper, where “Pattern of Altered Plasma Elemental Phosphorus, Calcium, Zinc, and Iron in Alzheimer’s Disease” was incorrectly given as “Pattern of Altered Plasma Elemental Phosphorus, Calcium, Selenium, Iron and Copper in Alzheimer’s Disease”.
By Angela Hodges, Andrew Simmons Verified, Simon Lovestone, Michael Weiner| Neurology Verified AbstractObjective To determine whether transcriptional risk scores (TRSs), a summation of polarized expression levels of functional genes, reflect the risk of Alzheimer disease (AD). Methods Blood transcriptome data were from Caucasian participants, which included AD, mild cognitive impairment, and cognitively normal controls (CN) in the Alzheimer's Disease Neuroimaging Initiative (ADNI, n = 661) and AddNeuroMed (n = 674) cohorts.
Company Info
International Journal of Geriatric Psychiatry
Oxford, England, United Kingdom
+44 1865 277227